Newsmakers

Nightfood Ice Cream (OTC: NGTF) Obtains Distribution Commitment from Additional Top-10 Supermarket Chain

TARRYTOWN, NY, Nov. 20, 2019–  Nightfood, Inc. (otcqb:NGTF), the award-winning ice cream company addressing America’s $50 billion-dollar nighttime snacking problem, yesterday received confirmation that sleep-friendly Nightfood ice cream will soon be made available in a […]

Newsmakers

CytoDyn’s (OTC: CYDY) Lead Product Candidate Leronlimab (PRO 140) Inhibits Colon Carcinoma Metastases to Liver and Lung in Preclinical Studies

CytoDyn will file for expanded access IND for patients with pancreatic, prostate, lung, breast, liver and melanoma cancers VANCOUVER, Washington, Nov 19, 2019  — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology […]

Newsmakers

NexTechAR (OTC: NEXCF) Teams with LivePerson (NASDAQ: LPSN) to Personalize Augmented Reality Through Conversational Commerce

One-of-a-kind, transformative technology for retailers combines messaging and AR experiences NEW YORK and TORONTO, Nov 19, 2019– NEW YORK and TORONTO, Nov. 19, 2019 — NexTech AR Solutions (the “Company” or “NexTech”) (otcqb:NEXCF) (NTAR)(N29), the […]

Healthcare

Hoth Therapeutics (NASDQ: HOTH) to Attend Benchmark’s 8th Annual Discovery 1×1 Conference

NEW YORK, Nov. 18, 2019  — Hoth Therapeutics, Inc. (NASDAQ: HOTH) (“HOTH” or the “Company”), a biopharmaceutical company focused on developing new generation therapies for dermatological disorders such as atopic dermatitis, chronic wounds, psoriasis and acne, […]

Healthcare

Hoth Therapeutics (NASDAQ: HOTH) Initiates Preclinical Study Including Topical Form of Aprepitant for Dermatological Treatment Relating to Side Effects of Cancer Medication

NEW YORK, Nov. 14, 2019 — Hoth Therapeutics, Inc. (NASDAQ: HOTH) (“HOTH” or the “Company”), a biopharmaceutical company focused on developing new generation therapies for dermatological disorders such as atopic dermatitis, chronic wounds, psoriasis and acne, […]

Healthcare

CytoDyn (OTC: CYDY) Receives IRB Approval To Proceed With Compassionate Use Of Leronlimab For Patients With Triple-Negative Breast Cancer

VANCOUVER, Washington, Nov. 12, 2019 – CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today it has […]

Healthcare

First Patient in CytoDyn’s (OTC: CYDY) Triple-Negative Metastatic Breast Cancer Trial Shows Significant Reduction in Circulating Tumor Cells (CTC) and Reduced Tumor Size

Breakthrough Therapy designation filing possible if more patients show similar positive results VANCOUVER, Washington, Nov. 11, 2019  — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 […]

Newsmakers

Medicine Man Technologies, Inc. (OTC: MDCL) to Host Q3 2019 Conference Call on November 11, 2019

DENVER, Nov. 7, 2019– Medicine Man Technologies, Inc. (otcqx:MDCL) (“Medicine Man Technologies” or the “Company”), announced today that it will host a conference call to discuss operational and financial highlights from its third quarter 2019 on […]

Consumer

Nightfood Ice Cream (OTC: NGTF) Engages Independent Natural Food Brokers to Expand Distribution West of Mississippi, Securing Additional New Supermarket Chains

Tarrytown, NY, Nov 05, 2019 — — Nightfood, Inc. (otcqb:NGTF), the start-up ice cream company addressing America’s $50 billion-dollar nighttime snacking problem, has engaged Independent Natural Food Brokers (INFB) to represent the Nightfood line to […]